Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines
- gdelacruz57
- Oct 25, 2023
- 1 min read
La Jolla, CA, October 24, 2023 (Business Wire) -- Rampart Bioscience, Inc., a biotechnology firm dedicated to the advancement of next-generation announces an $85 million Series A financing. It is focused on medical solutions that alleviate the burdens imposed by disease and conventional treatments.
Read full article here.
Comments